Profil Institute for Clinical Research Appoints Dr. Andrew Krentz as Senior Director of Scientific Services
Profil® Institute for Clinical Research, Inc. announced the appointment of Dr. Andrew Krentz as Senior Director of Scientific Services. Dr. Krentz, who is currently a senior scientific consultant for Profil Institute, will take on his new position in October following his relocation from the UK to San Diego. In his new role he will oversee Profil Institute’s scientific services department and its integrated, science-driven approach from clinical trial protocol design to the publication of metabolic studies.
Dr. Krentz trained in metabolic medicine at leading academic institutions in the UK and US. After obtaining his MD thesis Metabolic Studies in Insulin Resistance from the University of Birmingham he expanded his research repertoire at the University of New Mexico School of Medicine in Albuquerque. He pursued his clinical academic career as Consultant Physician in Diabetes and Endocrinology at Southampton University Hospitals and Honorary Senior Lecturer at the University of Southampton before returning to the US to take up a British Heart Foundation International Research Fellowship at the University of California San Diego.
Dr. Krentz comes to Profil Institute from the Bedfordshire and Hertfordshire Postgraduate Medical School where he currently holds a position at Associate Professor level within the Institute of Diabetes for Older People (IDOP). Dr. Krentz’s forthcoming appointment as Visiting Professor at the University of Bedfordshire will maintain his academic affiliation with IDOP.
Dr. Krentz’s expertise in metabolic and vascular medicine is reflected by his membership of several prominent national and international scientific societies. In the UK he is a council member of the Lipids, Metabolism & Vascular Disease Section of the Royal Society of Medicine. He is an elected member of the British Hypertension Society and is accredited as a clinical specialist in hypertension by the European Society for Hypertension. He is also a member of the European Group for the study of Insulin Resistance and the Diabetes and Cardiovascular Disease Study Group of the European Association for the Study of Diabetes.
Dr. Krentz is the author of a number of well-received textbooks on diabetes and vascular medicine and has published more than 150 original articles, reviews, editorials, and book chapters. Currently he is an associate editor for Diabetic Medicine (the official journal of Diabetes UK) and has served on editorial boards of the British Journal of Diabetes & Vascular Disease; Diabetes & Vascular Disease Research; Diabetes, Obesity & Metabolism; Drugs; Drugs & Aging and Treatments in Endocrinology.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
